Workshop
Event Title
Partners in Progress: Cancer Patient Advocates and FDA Public Workshop
November 13, 2017
- Date:
- November 13, 2017
- Time:
- 9:00 AM - 4:00 PM ET
Partners in Progress: Cancer Patient Advocates and FDA Public Workshop
The FDA Oncology Center of Excellence held its first annual educational workshop for new cancer patient advocates, "Partners in Progress: Cancer Patient Advocates and FDA," on Nov. 13, 2017, at the FDA White Oak Campus.
The objectives were to provide basic training on the role of the FDA and cancer patient advocates in oncology product development. This broad introduction to FDA regulatory aspects of oncology product development is most relevant to attendees with limited knowledge and experience in cancer product development and patient advocacy. The following organizations provided support for this meeting: the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), and the American Society of Hematology (ASH).
Webcast Information:
FDA archived webcast of this meeting is available as follows:
Workshop Information:
Presentations
- Jon Retzlaff, AACR Overview
- Jeannine Salamone and Shimere Sherwood, ASCO Overview
- Suzanne Leous, ASH Overview
- Peter Marks, CBER Accelerating Developments & Innovative Products
- Virginia Kwitkowski, Myth Busters
- Gideon Blumenthal, Primer on Drug Development
- Deb Miller, The Patient’s Voice
- Kevin Wright, Marketing and Advertising in Drug Development
- Patty Spears, Patient Advocate
- Aviva Krauss, Patient Representative Participation
- Paul Kluetz, Patient-Focused Drug Development and Cancer Trials
- Vishal Bhatnagar, Patient Experience in Oncology
- Heather Benz, Patient Preferences Studies
- Joohee Sul, Expanded Access Program for Drugs and Biologics
- Carol Pamer, Exploration of Real World Data
- Steven Lemery, Pembrolizumab for Treatment of MSI-H/dMMR Cancers
- Tara Ryan, Update from CDRH
- Najat Bouchkouj, CBER Recent Cancer Product Approvals